Microfluidic Reconstitution of Tumor Microenvironment for Nanomedical Applications

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Cancer Research

Background:

• Nanoparticles show promise for cancer diagnosis and therapy.
• Clinical translation of nanoparticles is hindered by inadequate preclinical models that fail to replicate tumor microenvironments (TMEs).

Purpose of the Study:

• To review recent advancements in microfluidic models for simulating TME characteristics.
• To highlight the application of these models in evaluating nanomedical tools for cancer treatment.

Main Methods:

• Utilizing microfluidic devices to recapitulate TME physiological cues, including extracellular matrix, shear stress, and gradients.
• Employing methods for de-coupling microenvironmental features and spatiotemporal control.
• Implementing high-throughput in situ readouts.

Main Results:

• Microfluidic platforms successfully mimic key TME features, offering a more accurate preclinical evaluation.
• These systems enable detailed analysis of nanoparticle behavior within a simulated tumor context.
• Progress in reconstituting the physiological microenvironment for nanomedical research.

Conclusions:

• Microfluidic models are crucial for bridging the gap between preclinical cancer nanomedicine and clinical outcomes.
• These advanced in vitro systems enhance the evaluation of nanoparticle-based cancer diagnostics and therapeutics.
• Further development of microfluidic approaches will accelerate the clinical translation of nanomedicines.